The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

A group of senators are pressing the US Food and Drug Administration (FDA) to provide a more predictable pathway to market for generic opioid painkillers in the hopes of ensuring that new versions of ...

Replacing high-cost generics with cheaper medications that have the same clinical benefit could have cut down spending and saved patients about 88%, according to Johns Hopkins research published in ...